Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - Kintara Therapeutics, Inc. | f10k2017ex32-2_delmar.htm |
| EX-32.1 - CERTIFICATION - Kintara Therapeutics, Inc. | f10k2017ex32-1_delmar.htm |
| EX-31.2 - CERTIFICATION - Kintara Therapeutics, Inc. | f10k2017ex31-2_delmar.htm |
| EX-31.1 - CERTIFICATION - Kintara Therapeutics, Inc. | f10k2017ex31-1_delmar.htm |
| EX-23.1 - CONSENT OF ERNST & YOUNG LLP - Kintara Therapeutics, Inc. | f10k2017ex23-1_delmar.htm |
| 10-K - ANNUAL REPORT - Kintara Therapeutics, Inc. | f10k2017_delmarpharma.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Forms S-3 (No. 333-189337, No. 333-213601, and No. 333-213600) of DelMar Pharmaceuticals, Inc. of our report dated September 12, 2016 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Chartered Professional Accountants
Vancouver, British Columbia
September 27, 2017